BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26578537)

  • 1. Depression, Antidepressant Use, and Postmenopausal Breast Cancer Risk.
    Brown SB; Hankinson SE; Arcaro KF; Qian J; Reeves KW
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):158-64. PubMed ID: 26578537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression, Antidepressant Use, and Breast Cancer Risk in Pre- and Postmenopausal Women: A Prospective Cohort Study.
    Reeves KW; Okereke OI; Qian J; Tamimi RM; Eliassen AH; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):306-314. PubMed ID: 29263188
    [No Abstract]   [Full Text] [Related]  

  • 3. Marginal structural models for the estimation of the risk of Diabetes Mellitus in the presence of elevated depressive symptoms and antidepressant medication use in the Women's Health Initiative observational and clinical trial cohorts.
    Frisard C; Gu X; Whitcomb B; Ma Y; Pekow P; Zorn M; Sepavich D; Balasubramanian R
    BMC Endocr Disord; 2015 Oct; 15():56. PubMed ID: 26458393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant Use and Risk of Colorectal Cancer in the Women's Health Initiative.
    Kiridly-Calderbank JF; Sturgeon SR; Kroenke CH; Reeves KW
    Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):892-898. PubMed ID: 29789327
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of depression before breast cancer diagnosis on mortality among postmenopausal women.
    Liang X; Margolis KL; Hendryx M; Reeves K; Wassertheil-Smoller S; Weitlauf J; Danhauer SC; Chlebowski RT; Caan B; Qi L; Lane D; Lavasani S; Luo J
    Cancer; 2017 Aug; 123(16):3107-3115. PubMed ID: 28387934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal women.
    Ma Y; Balasubramanian R; Pagoto SL; Schneider KL; Culver AL; Olendzki B; Tinker L; Liu S; Safford M; Sepavich DM; Rosal MC; Ockene JK; Carnethon M; Zorn M; Hébert JR
    Diabetes Care; 2011 Nov; 34(11):2390-2. PubMed ID: 21911776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Baseline Depressive Symptoms with Prevalent and Incident Pre-Hypertension and Hypertension in Postmenopausal Hispanic Women: Results from the Women's Health Initiative.
    Zambrana RE; López L; Dinwiddie GY; Ray RM; Eaton CB; Phillips LS; Wassertheil-Smoller S
    PLoS One; 2016; 11(4):e0152765. PubMed ID: 27124184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI).
    Wassertheil-Smoller S; Shumaker S; Ockene J; Talavera GA; Greenland P; Cochrane B; Robbins J; Aragaki A; Dunbar-Jacob J
    Arch Intern Med; 2004 Feb; 164(3):289-98. PubMed ID: 14769624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant use, depressive symptoms, and incident frailty in women aged 65 and older from the Women's Health Initiative Observational Study.
    Lakey SL; LaCroix AZ; Gray SL; Borson S; Williams CD; Calhoun D; Goveas JS; Smoller JW; Ockene JK; Masaki KH; Coday M; Rosal MC; Woods NF
    J Am Geriatr Soc; 2012 May; 60(5):854-61. PubMed ID: 22568404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Combined Association of Modifiable Risk Factors with Breast Cancer Risk in the Women's Health Initiative.
    Arthur R; Wassertheil-Smoller S; Manson JE; Luo J; Snetselaar L; Hastert T; Caan B; Qi L; Rohan T
    Cancer Prev Res (Phila); 2018 Jun; 11(6):317-326. PubMed ID: 29483073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between prediagnosis depression and mortality among postmenopausal women with colorectal cancer.
    Liang X; Hendryx M; Qi L; Lane D; Luo J
    PLoS One; 2020; 15(12):e0244728. PubMed ID: 33382778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.
    Chlebowski RT; Rohan TE; Manson JE; Aragaki AK; Kaunitz A; Stefanick ML; Simon MS; Johnson KC; Wactawski-Wende J; O'Sullivan MJ; Adams-Campbell LL; Nassir R; Lessin LS; Prentice RL
    JAMA Oncol; 2015 Jun; 1(3):296-305. PubMed ID: 26181174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are depressive symptoms associated with cancer screening and cancer stage at diagnosis among postmenopausal women? The Women's Health Initiative observational cohort.
    Aggarwal A; Freund K; Sato A; Adams-Campbell LL; Lopez AM; Lessin LS; Ockene J; Wallace RB; Williams CD; Bonds DE
    J Womens Health (Larchmt); 2008 Oct; 17(8):1353-61. PubMed ID: 18788983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use and breast cancer: prospective results from the Women's Health Initiative.
    Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
    J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association of the C-Reactive Protein Inflammatory Biomarker with Breast Cancer Incidence and Mortality in the Women's Health Initiative.
    Nelson SH; Brasky TM; Patterson RE; Laughlin GA; Kritz-Silverstein D; Edwards BJ; Lane D; Rohan TE; Ho GYF; Manson JE; LaCroix AZ
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1100-1106. PubMed ID: 28292922
    [No Abstract]   [Full Text] [Related]  

  • 17. Periodontal Disease and Breast Cancer: Prospective Cohort Study of Postmenopausal Women.
    Freudenheim JL; Genco RJ; LaMonte MJ; Millen AE; Hovey KM; Mai X; Nwizu N; Andrews CA; Wactawski-Wende J
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):43-50. PubMed ID: 26689418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and breast cancer stage and mortality in the Women's Health Initiative.
    Desai P; Lehman A; Chlebowski RT; Kwan ML; Arun M; Manson JE; Lavasani S; Wasswertheil-Smoller S; Sarto GE; LeBoff M; Cauley J; Cote M; Beebe-Dimmer J; Jay A; Simon MS
    Cancer Causes Control; 2015 Apr; 26(4):529-39. PubMed ID: 25736184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.
    Chen Z; Maricic M; Bassford TL; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS
    Arch Intern Med; 2005 Mar; 165(5):552-8. PubMed ID: 15767532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer recurrence in relation to antidepressant use.
    Chubak J; Bowles EJ; Yu O; Buist DS; Fujii M; Boudreau DM
    Cancer Causes Control; 2016 Jan; 27(1):125-36. PubMed ID: 26518198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.